View of The Effects of Selective Serotonin Reuptake Inhibitors on Neurological and Depressive Symptoms in Multiple Sclerosis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials: SSRIs in Multiple Sclerosis: Meta-analysis | Galen Medical Journal

Return to Article Details The Effects of Selective Serotonin Reuptake Inhibitors on Neurological and Depressive Symptoms in Multiple Sclerosis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials: SSRIs in Multiple Sclerosis: Meta-analysis